Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 USD | +1.59% | +3.92% | +25.64% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.64% | 2.2B | |
+5.58% | 80.86B | |
+3.69% | 75.4B | |
-14.62% | 52.54B | |
-24.56% | 51.47B | |
+31.16% | 48.04B | |
+17.75% | 40.73B | |
+55.21% | 35.61B | |
-10.24% | 24.47B | |
-21.24% | 22.73B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- BofA Securities Starts Cellebrite DI at Buy with $11 Price Target